How to Buy Affimed Nv Stock
Affimed Nv
Affimed N. V. , a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe.
Affimed Nv stock last closed at $0.76, down 14.01% from the previous day, and has decreased 73.23% in one year. It has underperformed other stocks in the Biotechnology industry by 0.61 percentage points. Affimed Nv stock is currently +37.27% from its 52-week low of $0.55, and -77.79% from its 52-week high of $3.40.
There are currently 149.34M shares of AFMD outstanding. The market cap of AFMD is $112.75M. In the last 24 hours, 1.9M AFMD shares were traded.
How to Buy Affimed Nv Stock
Wondering how to invest in Affimed Nv stock? Here's how.
- Figure out where to buy Affimed Nv stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you determine where to buy Affimed Nv stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit money your investment account: Choose your payment method and add your information.
- Analyze Affimed Nv stock: The Affimed Nv ticker symbol is AFMD. Is Affimed Nv stock a good investment? Should you buy shares of AFMD? How do AFMD's underlying business fundamentals look? Do top analysts think Affimed Nv is a good buy? Why has AFMD's stock price moved recently? (Hint: Our stock market research tools can help you figure out if AFMD is a good stock to buy).
- Place your AFMD purchase: Decide if you will purchase AFMD shares at the current market price or use a limit order to buy AFMD shares at a specific price.
- Monitor your AFMD position: Create a watchlist to get the latest news on your position in Affimed Nv stock.
Step 1: Figure out where to buy Affimed Nv stock
You will need a brokerage account in order to access the NASDAQ market and buy AFMD stock.
Our recommended brokerage: eToro
Based on our research, eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Tech to Healthcare, New York to Shanghai — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro today.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked your brokerage, you need to fill out some personal details so you can invest in AFMD stock today.
How to Open a New Account on eToro
- Click here to get started.
- Provide your personal info to open a new brokerage account.
- Send your details by pressing the "Create Account" button.
Step 3: Deposit money your investment account
Now that you have finished signing up on our top ranked stock app, you can securely and quickly fund your account:
Check out the tutorial below for more details transferring money into your investment account.
Step 4: Analyze Affimed Nv stock
After you have chosen the best place to buy Affimed Nv stock, it's critical to evaluate their stock prior to investing, so you truly comprehend the risk and upside.
Overview of key AFMD info
Affimed Nv Due Diligence Checks
WallStreetZen was built to help everyday investors do more accurate fundamental analysis.
You can view all of the due diligence checks on AFMD's stock page.
Is AFMD stock properly valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge AFMD's true value.
Using relative valuations ratios:
- AFMD may be undervalued based on its P/B ratio of 0.82x, relative to Biotechnology industry P/B ratio of 5.21x
You can do additional valuation research on AFMD's stock here.
AFMD Financials at a glance
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the AFMD balance sheet.
- There are more short-term assets than long-term liabilities on the AFMD balance sheet.
- AFMD has cash burn of 121183516. It has sufficient cash and short-term investments to cover this for at least one year.
- AFMD has a low debt to equity ratio of 0.34.
Negative Health Checks:
- AFMD has $171.26M in cash and short term investments. This is not sufficient to cover its annual cash burn of $121.18M.
- AFMD profit margin has gone down from -205.9% to -267.6% in the past year.
- Total AFMD debt is higher than 5 years ago, relative to shareholder equity.
Is AFMD stock a Buy, Hold, or Sell, according to analysts?
Out of 6 Wall Street analysts who give forecasts on AFMD, the consensus analyst rating on Affimed Nv is a Strong Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
Most Recent AFMD Analyst Forecasts
Swayampakula Ramakanth, a bottom 30% analyst from HC Wainwright & Co. maintains AFMD with a buy rating and lowers their AFMD price target from $6.00 to $5.00, on Jun 5, 2023.
Yanan Zhu, a bottom 2% analyst from Wells Fargo assumes AFMD with a strong buy rating and announces their AFMD price target of $7.00, on Mar 27, 2023.
Bradley Canino, a bottom 1% analyst from Stifel Nicolaus maintains AFMD with a hold rating and lowers their AFMD price target from $2.00 to $1.00, on Mar 24, 2023.
James Shin, a bottom 34% analyst from Wells Fargo maintains AFMD with a strong buy rating and lowers their AFMD price target from $8.00 to $7.00, on Dec 12, 2022.
Do Kim, a bottom 11% analyst from Piper Sandler maintains AFMD with a strong buy rating and lowers their AFMD price target from $7.00 to $6.00, on Dec 12, 2022.
You can dig deeper into what analysts are saying on the Affimed Nv stock forecast page.
Metrics for Advanced AFMD Traders
AFMD Revenue
Last year, AFMD revenue was $41.60M. Over the past 5 year, AFMD's revenue has grown by 73.42% per year. This was slower than the Biotechnology industry average of 90.14%.
Find out more about AFMD's earnings and revenue performance here.
What are AFMD insiders up to?
In the last 12 months, insiders at AFMD have not bought or sold any shares.
Learn more about who owns AFMD shares here.
Does AFMD stock generate passive income?
No, Affimed Nv doesn't provide an income stream by paying out dividends.
AFMD Social Trading Data
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your AFMD purchase
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually fine. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a specific dollar amount, use a limit order.
Press the Open Trade button and eToro will place your order.
If you want additional help with investing in stocks on eToro, watch the helpful video below:
Step 6: Monitor your AFMD position
Now that you own some AFMD shares, you'll want to keep up with your new investment.
Make a watchlist to see the latest developments about your AFMD stock.
AFMD Feed
How to Buy Stock in Affimed Nv
To reiterate, here are the 6 steps to buy stock in Affimed Nv:
- Figure out where to buy Affimed Nv stock
- Sign up for a brokerage account
- Deposit money your investment account
- Analyze Affimed Nv stock
- Place your AFMD purchase
- Monitor your AFMD position
If you are looking for a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get the latest news on your new investment in Affimed Nv, create a watchlist today.
More Content You Might Like
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.